Practical insights on due diligence in the life sciences and healthcare sector covering pharmaceutical, biotechnology, diagnostics and medical devices area. Get acquainted with state-of-the-art concepts and practices to make optimal decisions.

AI in Pharma Due Diligence: Leveraging for Licensing and M&A

Introduction Due diligence (DD) in pharmaceutical licensing and M&A has always been a resource-intensive exercise. Thousands of documents - clinical data packages, IP portfolios, regulatory submissions, commercial contracts, manufacturing records,…

Continue ReadingAI in Pharma Due Diligence: Leveraging for Licensing and M&A

Advanced Competitive Benchmarking Techniques in the Biopharma Industry

Introduction In the fiercely competitive landscape of the biopharmaceutical industry, staying ahead requires not just innovation but also a keen understanding of the competitive environment. Competitive benchmarking is a strategic…

Continue ReadingAdvanced Competitive Benchmarking Techniques in the Biopharma Industry

Pharmaceutical R&D Trends 2025: Industry Insights and Strategic Shifts

Introduction The pharmaceutical industry is at a critical inflection point in 2025, with research and development (R&D) continuing to grow despite global economic pressures and shifting regulatory landscapes. As thousands…

Continue ReadingPharmaceutical R&D Trends 2025: Industry Insights and Strategic Shifts

Leveraging Comparative Evaluation in Due Diligence of Biopharma In-Licensing and Partnering Deals

Introduction The biopharmaceutical industry landscape is constantly evolving, and in-licensing and partnering deals are vital corporate strategies for driving innovation, devising new products, and gaining a competitive edge in the…

Continue ReadingLeveraging Comparative Evaluation in Due Diligence of Biopharma In-Licensing and Partnering Deals

Looking beyond Generics in Commercial Due Diligence of Generics Pharmaceutical Businesses

How to Conduct Robust Commercial Due Diligence by Looking Beyond Generics in Pharma Businesses Investors need to look beyond generics in the pharmaceutical commercial due diligence (CDD) for investment in…

Continue ReadingLooking beyond Generics in Commercial Due Diligence of Generics Pharmaceutical Businesses

Determining True Addressable Market in Healthcare and Life Sciences Commercial Due Diligence

How to Accurately Assess the True Addressable Market in Healthcare and Life Sciences Due Diligence Determining the appropriate addressable market is often one of the critical success factors in commercial…

Continue ReadingDetermining True Addressable Market in Healthcare and Life Sciences Commercial Due Diligence

Digital Health and IoT are attractive opportunities for Life Sciences Investors and Pharmaceutical Companies

Win-win Investment Opportunities in Digital Health and IoT for Life Sciences Investors and Pharma Industry Digital Health and IoT are attractive opportunities for Life Sciences Investors and Pharmaceutical companies. The…

Continue ReadingDigital Health and IoT are attractive opportunities for Life Sciences Investors and Pharmaceutical Companies